SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.810.0%3:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: schadenfreude who wrote (7602)10/30/1998 5:08:00 PM
From: aknahow  Read Replies (2) of 17367
 
IMO, No. And No. Glasgow scale was used to determine seriousness of the illness. Meaning that even without the LBP diagnostic tool there was a tool for measuring severity of this disease. Don't mean the new diagnostic tool would not be of use here also but just that given the specific characteristics of meningococcal infection and the years of use of this scale, it seems prognosis is less unclear than in other sepsis infections. Opinion of one without any medical nor scientific background, so take it for what it's worth.

DSMB meets just prior of end of trial. There are some benefits of a recommendation for an early halt even at that point. But obviously I don't know what they will recommend.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext